Moreover, inhibition of the STAT3 pathway by the specific small molecule inhibitor C-188-9 has been demonstrated to decrease fibroblast-to-myofibroblast differentiation in vitro and development of pulmonary fibrosis in bleomycin-treated mice in vivo [20]. This evidence concerns the gene STAT3 and pulmonary fibrosis.